跳至主要内容
临床试验/NCT05786807
NCT05786807招募中4 期

Effect of H. Pylori Eradication on Alleviating Symptoms in Functional Dyspepsia Patients: A Multicenter, Comparative Study

Wonkwang University Hospital1 个研究点 分布在 1 个国家目标入组 315 人开始时间: 2022年3月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
315
试验地点
1
主要终点
Rate of disappearance of dyspepsia symptoms

研究概览

简要总结

In patients with Helicobacter pylori-positive functional dyspepsia, long-term follow-up for 6 months after standard triple therapy first-line eradication treatment, the rate of symptom disappearance and degree of improvement of functional dyspepsia were confirmed through changes in symptom scores and changes in drug usage, and eradication treatment The purpose of this study is to confirm the rate of symptom disappearance according to the results.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
19 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female outpatients between the ages of 19 and 75
  • Who have symptoms of functional dyspepsia (early fullness, postprandial discomfort, epigastric pain, epigastric soreness) that correspond to Rome criteria 4 (diagnostic criteria questionnaire)

排除标准

  • Small intestine and large intestine disease within 6 months of the screening visit (Visit 1)
  • liver, pancreatobiliary disease within 6 months of the screening visit (Visit 1)
  • peptic ulcer within 6 months of the screening visit (Visit 1)

研究组 & 干预措施

Tegoprazan 50mg

Experimental

single group

干预措施: K-CAB (Drug)

结局指标

主要结局

Rate of disappearance of dyspepsia symptoms

时间窗: Day 176

Rate of disappearance of dyspepsia symptoms after 6 months of eradication treatment

次要结局

  • Improvement rate of dyspepsia symptoms(Day 92, Day 176)
  • Number of days of dyspepsia drug administration(Day 92, Day 176)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Suck Chei Choi

Coordinating Investigator

Wonkwang University Hospital

研究点 (1)

Loading locations...

相似试验

Effect of H. Pylori Eradication on Alleviating... | 临床试验